跳至主要内容
临床试验/DRKS00031243
DRKS00031243尚未招募Unknown

Evaluation of medical benefits and positive effects on patient supply of the certified medical product PINK! Leben in a multi-centre, randomized controlled trial with breast cancer patients - PINK! Leben

PINK! gegen Brustkrebs0 个研究点目标入组 194 人开始时间: 2023年3月7日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
194

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • German speaking
  • Proof of the diagnosis of a histologically confirmed breast carcinoma
  • willingness to accept the PINK! complete the life course
  • Willingness to fill out online questionnaires (8 in total)
  • Presence of an email address
  • Presence of a laptop / computer / tablet
  • Therapy situation:
  • (1) still at least 8 weeks in therapy
  • (2) OR discharge for aftercare (outpatient) (up to 6 months after the end of therapy)
  • (3) OR upon commencement of 3 or 4 week inpatient rehabilitation

排除标准

  • Planned psycho-oncological care during therapy or rehabilitation
  • Use of another app / online course to reduce psychological stress (also PINK! Coach)
  • Strong previous psychological stress: currently severe depression (F32.2, F32.3, F33.2, F33.3, possibly also F31.4, F31.5), acute suicidality (no ICD diagnosis, as symptom R45.8 , Z91.8)

研究者

发起方
PINK! gegen Brustkrebs

相似试验

Evaluation of medical benefits and positive effects... | 临床试验